GL1X · GenesisL1 explorer

MolNFT v1 · #102114 · protein

Retinoic acid receptor alpha in complex with (E)-3-(3'-allyl-6- hydroxy-[1,1'-biphenyl]-3-YL)ACRYLIC acid and a fragment of the coactivator TIF2

4OC7 · Retinoic acid receptor rxr-alpha: “Retinoic acid receptor alpha in complex with (E)-3-(3'-allyl-6- hydroxy-[1,1'-biphenyl]-3-YL)ACRYLIC acid and…”. X-ray diffraction, 1 ligand (2QO), 3 pockets (best druggability 0.82). MolNFT v1…

PDB
4OC7
Type
protein
Length
223 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
2QO
Pockets
3 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21368% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1080% helix, 0% strandQ15596

Ligands and binding sites

  • 2QO · (2E)-3-[6-hydroxy-3'-(prop-2-en-1-yl)biphenyl-3-yl]prop-2-enoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11930.820.96252QO
21110.550.8417empty
31220.430.7619empty

Interfaces

1 interface between chains.

  • A–B · 529 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4OC7 · Retinoic acid receptor alpha in complex with (E)-3-(3'-allyl-6-hydroxy-[1,1'-biphenyl]-3-y… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.